Loss-of-function genetic diseases and the concept of pharmaceutical targets

被引：0
|
作者：
Ryan R. Brinkmann
Marie-Pierre Dubé
Guy A. Rouleau
Andrew C. Orr
Mark E. Samuels
机构：
来源：
Nature Reviews Genetics | 2007年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：404 / 404
相关论文
共 50 条
  • [41] Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind
    Boisson, Bertrand
    Quartier, Pierre
    Casanova, Jean-Laurent
    CURRENT OPINION IN IMMUNOLOGY, 2015, 32 : 90 - 105
  • [42] Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function
    Castro, Maria E.
    Leal, Juan F. M.
    Lleonart, Matilde E.
    Ramon y Cajal, Santiago
    Carnero, Amancio
    CARCINOGENESIS, 2008, 29 (07) : 1343 - 1350
  • [43] Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies
    Krueger, Johanna
    Schubert, Julian
    Kegele, Josua
    Labalme, Audrey
    Mao, Miaomiao
    Heighway, Jacqueline
    Seebohm, Guiscard
    Yan, Pu
    Koko, Mahmoud
    Aslan-Kara, Kezban
    Caglayan, Hande
    Steinhoff, Bernhard J.
    Weber, Yvonne G.
    Keo-Kosal, Pascale
    Berkovic, Samuel F.
    Hildebrand, Michael S.
    Petrou, Steven
    Krause, Roland
    May, Patrick
    Lesca, Gaetan
    Maljevic, Snezana
    Lerche, Holger
    EBIOMEDICINE, 2022, 84
  • [44] Establishing genetic loss-of-function mutants for Craniosynostosis (CS) via Calvaria Formation modeling
    Karasik, David
    Matok, Lital Ashtamkar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 115 - 115
  • [45] NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease
    Schwerd, T.
    Bryant, R. V.
    Pandey, S.
    Capitani, M.
    Meran, L.
    Cazier, J-B
    Jung, J.
    Mondal, K.
    Parkes, M.
    Mathew, C. G.
    Fiedler, K.
    McCarthy, D. J.
    Sullivan, P. B.
    Rodrigues, A.
    Travis, S. P. L.
    Moore, C.
    Sambrook, J.
    Ouwehand, W. H.
    Roberts, D. J.
    Danesh, J.
    Russell, R. K.
    Wilson, D. C.
    Kelsen, J. R.
    Cornall, R.
    Denson, L. A.
    Kugathasan, S.
    Knaus, U. G.
    Serra, E. G.
    Anderson, C. A.
    Duerr, R. H.
    Mcgovern, D. P. B.
    Cho, J.
    Powrie, F.
    Li, V. S. W.
    Muise, A. M.
    Uhlig, H. H.
    MUCOSAL IMMUNOLOGY, 2018, 11 (02) : 562 - 574
  • [46] Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk
    Bobbili, Dheeraj Reddy
    Banda, Peter
    Krueger, Rejko
    May, Patrick
    JOURNAL OF MEDICAL GENETICS, 2020, 57 (09) : 617 - 623
  • [47] Constitutional loss-of-function mutations in telomerase are genetic risk factors for acute myeloid leukemia
    Calado, Rodrigo T.
    Regal, Joshua A.
    Yewdell, William T.
    Falcao, Roberto P.
    Figueiredo, Leandro
    Estey, Elihu H.
    Zago, Marco A.
    Hills, Mark
    Chanock, Stephen T.
    Lansdorp, Peter M.
    Young, Neal S.
    BLOOD, 2007, 110 (11) : 13A - 13A
  • [48] A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability
    Cantisani, Maria Carmela
    Parascandolo, Alessia
    Perala, Merja
    Allocca, Chiara
    Fey, Vidal
    Sahlberg, Niko
    Merolla, Francesco
    Basolo, Fulvio
    Laukkanen, Mikko O.
    Kallioniemi, Olli Pekka
    Santoro, Massimo
    Castellone, Maria Domenica
    ONCOTARGET, 2016, 7 (19) : 28510 - 28522
  • [49] Cellular prion modulates neuron-glia networks: A loss-of-function view of prion diseases
    Lima, F. R.
    Arantes, C. P.
    Martins, V. R.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 7 - 7
  • [50] Therapeutic strategies for diseases caused by loss-of-function mutations in G protein-coupled receptors
    Wang, Wei
    Guo, Dong-Yu
    Tao, Ya-Xiong
    G PROTEIN SIGNALING PATHWAYS IN HEALTH AND DISEASE, 2019, 161 : 181 - 210
12345